The Uveal Melanoma market reached a value of USD 1,000 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,600 Million by 2035, exhibiting a growth rate (CAGR) of 4.28% during ...

As many as half of people diagnosed with uveal melanoma (ocular melanoma) go on to have what’s called metastatic disease. Most often, the cancer metastasizes (spreads) beyond the eye to the ...

The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

Fitzpatrick skin type influences both characteristics and outcomes associated with uveal melanoma and conjunctival melanoma.

Ocugen has received approval from the DSMB to begin dosing the second cohort of patients in a trial of OCU200 for diabetic ...

Int Ophthalmol Clin. 2015;55(1):23-43.

Background Increased pigmentation has been associated with cancer stem-cell-like behaviour and chemoresistance in uveal melanoma (UM) and cutaneous melanoma. Therefore, our present study determines ...

ABSTRACT: The rapid development of artificial intelligence (AI) technology is profoundly reshaping all walks of life, especially in the medical field. AI provides innovative tools for medical ...

Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial ...

Turnstone Biologics (NASDAQ:TSBX – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Thursday, March 20th. Analysts expect Turnstone Biologics to post ...